Sangamo Therapeutics
SGMO
#10607
Rank
โ‚น2.87 B
Marketcap
โ‚น6.95
Share price
0.00%
Change (1 day)
-84.64%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2023 (TTM): -โ‚น119.03

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น35.69. In 2022 the company made an earnings per share (EPS) of -โ‚น117.40 a decrease over its 2021 EPS that were of -โ‚น116.46.

EPS history for Sangamo Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น119.031.39%
2022-โ‚น117.400.81%
2021-โ‚น116.4633.33%
2020-โ‚น87.346.9%
2019-โ‚น81.7122.54%
2018-โ‚น66.681.43%
2017-โ‚น65.74-31.37%
2016-โ‚น95.8075.86%
2015-โ‚น54.4748.72%
2014-โ‚น36.63-17.02%
2013-โ‚น44.149.3%
2012-โ‚น40.38-39.44%
2011-โ‚น66.6829.09%
2010-โ‚น51.6522.22%
2009-โ‚น42.26-25%
2008-โ‚น56.353.45%
2007-โ‚น54.475.45%
2006-โ‚น51.6510%
2005-โ‚น46.96-9.09%
2004-โ‚น51.6530.95%
2003-โ‚น39.45-65.29%
2002-โ‚น113.6415.24%
2001-โ‚น98.613.96%
2000-โ‚น94.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น627.36-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,632-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น221.65-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น119.28 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น291.15 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น93.26-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น1,861-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.45-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA